Efficacy of tumor cell extracts in immunotherapy of murine EL-4 leukemia.

J. Cantrell,C. Mclaughlin,E. Ribi
IF: 11.2
1979-04-01
Cancer Research
Abstract:Abstract The ability of water-soluble tumor-associated antigens, in combination with chemotherapy, to cause regression of established EL-4 lymphocytic leukemia in C57BL/10 mice was determined. Extracts of EL-4 (G-) cells obtained by solubilization with 3 m KCI (SAE:EL-4) contained tumor-associated antigens as measured by immunodiffusion and inhibition of complement-dependent cytotoxicity using either rabbit or C57BL/10 anti-EL-4 sera. Tumors were established by s.c. injection of 2 to 5 × 10 4 ascites-grown EL-4 tumor cells. Twenty-five- or 100-µg quantities of mitomycin C were administered by intralesional injection 7 days after implantation when the tumors were about 4 mm in diameter. Intralesional injection 2 days later of oil-in-water emulsions containing 150 or 300 µg SAE:EL-4 caused complete regression of tumors in 50 to 80% ( p 2 PO 4 -NaHPO 4 , pH 7.3). Animals cured with combination therapy rejected a retransplant of EL-4 cells but not a transplant of B-16 tumor cells. High cytotoxic activity against EL-4 cells was detected in the sera from mice cured with either chemotherapy or chemoimmunotherapy. All of these findings demonstrate that it is possible to isolate tumor-associated antigens that act as immunostimulants and possess, when emulsified in oil droplets and combined with intratumor chemotherapy, high tumor regressive activity.
What problem does this paper attempt to address?